Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials

MC Lampi, CA Reinhart-King - Science translational medicine, 2018 - science.org
Tissues stiffen during aging and during the pathological progression of cancer, fibrosis, and
cardiovascular disease. Extracellular matrix stiffness is emerging as a prominent mechanical …
被引用次数：475 相关文章

Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials.

MC Lampi, CA Reinhart-King - Science Translational Medicine, 2018 - europepmc.org
Tissues stiffen during aging and during the pathological progression of cancer, fibrosis, and
cardiovascular disease. Extracellular matrix stiffness is emerging as a prominent mechanical …

Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials

MC Lampi, CA Reinhart-King - Science translational …, 2018 - pubmed.ncbi.nlm.nih.gov
Tissues stiffen during aging and during the pathological progression of cancer, fibrosis, and
cardiovascular disease. Extracellular matrix stiffness is emerging as a prominent mechanical …

[引用][C] Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials

MC Lampi, CA Reinhart-King - Science Translational Medicine, 2018 - cir.nii.ac.jp
Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to
clinical trials | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

Targeting extracellular matrix stiffness to attenuate disease: From molecular mechanisms to clinical trials.

MC Lampi, CA Reinhart-King - Science Translational …, 2018 - search.ebscohost.com
Targeting extracellular matrix stiffness holds clinical potential to attenuate pathological
progression in the emerging field of mechanomedicine. Tissues stiffen during aging and …